Optimization of allopurinol challenge: Sample purification, protein intake control, and the use of orotidine response as a discriminative variable improve performance of the test for diagnosing ornithine carbamoyltransferase deficiency

Clinical Chemistry

Volumn 45, Issue 7, 1999, Pages 995-1001

  Arranz, José A ^a   Riudor, Encarnació ^a   Rodés, Margarita ^b   Roig, Manuel ^a   Climent, Consuelo ^c   Rubio, Vicente ^c   Sentís, Margarita ^a   Burlina, Alberto ^d  

^a HOSPITAL MATERNO INFANTIL VALL D HEBRON   (Spain)

^b Institut de Bioquimica Clinica Barcelona   (Spain)

^c INSTITUTO DE BIOMEDICINA DE VALENCIA   (Spain)

^d UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; ORNITHINE CARBAMOYLTRANSFERASE; OROTIDINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENZYME DEFICIENCY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PROTEIN INTAKE; PURIFICATION; STANDARDIZATION;

MONOPLEX;

EID: 0032779266     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/45.7.995     Document Type: Article

References (13)

1. Brusilow SW, Horwich AL. Urea cycle enzymes. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited disease, 7th ed. New York: McGraw-Hill, 1995:1187-232.
2. Hauser ER, Finkelstein JE, Valle D, Brusilow SW. Allopurinol-induced orotidinuria. A test for mutations at the ornithine carbamoyltransferase locus in women. N Engl J Mad 1990;322:1641-5.
3. Burlina AB, Ferrari V, Dionisi-Vici C, Bordugo A, Zachello F, Tuchman M. Allopurinol challenge test in children. J Inherit Metab Dis 1992;15:707-12.
4. Sebesta I, Fairbanks LD, Davies PM, Simmonds JA, Leonard JV. The allopurinol loading test for identification of carriers of ornithine carbamoyl transferase deficiency: studies in a healthy control population and females at risk. Clin Chim Acta 1994;224:45-54.
5. Sebesta I, Krijt J, Fairbanks LD, Simmonds HA. The allopurinol loading test in detecting obligate heterozygotes for OCT deficiency. J Inherit Metab Dis 1994;17:133-4.
6. Tuchman M, Knopman DS, Shih VE. Episodic hyperammonemia in adult siblings with hyperornithinemia, hyperammonemia and homocitrullinuria syndrome. Arch Neurol 1990;47:1134-7.
7. Bonham JR, Downing M, Guthrie P, Olpin SE, Manning NJ, Pollit RJ, et al. Mitochondrial disorders may cause an increased excretion of orotic acid and a positive response to allopurinol loading [Abstract]. J Inherit Metab Dis 1997;20(Suppl 1):61 (P5.13).
8. Spada M, Guardamagna O, Rabier D, van der Meer SB, Parvy P, Bardet J, et al. Recurrent episodes of bizarre behavior in a boy with ornithine transcarbamylase deficiency: diagnostic failure of protein loading and allopurinol challenge tests. J Pediatr 1994;125:249-51.
9. Ahrens MJ, Berry SA, Whitley CB, Markowitz DJ, Plante RJ, Tuchman M. Clinical and biochemical heterogeneity in females of a large pedigree with ornithine transcarbamylase deficiency due to the R141Q mutation. Am J Med Genet 1996;66:311-5.
10. García-Pérez MA, Climent C, Briones P, Vilaseca MA, Rodés M, Rubio V. Missense mutations in codon 225 of ornithine transcarbamylase (OTC) result in decreased amounts of OTC protein: a hypothesis on the molecular mechanism of the OTC deficiency. J Inherit Metab Dis 1997;20:769-77.
11. Brusilow SW, Hauser E. Simple method of measurement of orotate and orotidine in urine. J Chromatogr 1989;493:388-91.
12. Tuchman M, Matsuda I, Munnich A, Malcom S, Strantnieks S, de Brie T. Proportions of spontaneous mutations in males and females with ornithine transcarbamylase deficiency. Am J Med Genet 1995;55:67-70.
13. Tuchman M. Inherited hyperammonemia. Chapter 12. In: Blau N, Duran M, Blaskovics ME, ads. Physician's guide to the laboratory diagnosis of metabolic disease. London: Chapman & Hall, 1996: 209-22.